BC Cancer | ClinicalTrials HQ

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment	pancreatic ductal adenocarcinoma	Recruiting	Not applicable	2026-09-16		NCT06574620
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity	Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genitourinary Cancer, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Unknown Primary, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Unknown Primary Tumors, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, digestive system disorder, digestive system neoplasm, female reproductive organ cancer, head and neck cancer, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, sarcoma, skin disorder, skin neoplasm	Recruiting	Phase 2	2026-09-16		NCT04273061
Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life	Atrophy, Body Weight, Body Weight Changes, Cachexia, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, Thinness, Weight Loss, muscular atrophy, nervous system disorder	Recruiting	Not applicable	2026-09-15		NCT07255001
Phase III Study of AK112 for NSCLC Patients	Non-Squamous Non-small Cell Lung Cancer	Active, not recruiting	Phase 3	2026-07-28		NCT06396065
DOTATOC PET/CT for Imaging NET Patients	Adenoma, Islet Cell, Carcinoma, Medullary, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Pituitary Neoplasms, Thoracic Neoplasms, Tumor Virus Infections, VIPoma, adenocarcinoma, adenoma, brain disorder, bronchial neoplasm, bronchogenic carcinoma, carcinoid tumor, carcinoma, central nervous system cancer, central nervous system disorder, cutaneous neuroendocrine carcinoma, endocrine system disorder, epithelial neoplasm, glioma, glucagonoma, hypothalamic disorder, hypothalamic neoplasm, lung disorder, lung neoplasm, malignant endocrine neoplasm, medulloblastoma, meningioma, neoplasm, nervous system disorder, neuroblastoma, neuroendocrine carcinoma, neuroendocrine neoplasm, neuroepithelial neoplasm, pancreas disorder, pancreatic endocrine carcinoma, pancreatic insulinoma, pancreatic neoplasm, paraganglioma, pheochromocytoma, pituitary gland adenoma, pituitary gland disorder, polyomavirus infectious disease, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma, supratentorial cancer, tumor of meninges, vascular cancer, viral infectious disease	Active, not recruiting	Not stated	2026-05-12		NCT03583528
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Nevus, Pigmented, Skin and Connective Tissue Diseases, blue nevus, melanocytic neoplasm, melanocytic nevus, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm	Recruiting	Phase 3	2026-02-25		NCT05549297
177Lu-HTK03170 in mCRPC With PSMA Positive Disease	metastatic prostate carcinoma	Enrolling by invitation	Phase 1 / Phase 2	2026-01-08		NCT05570994
[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Active, not recruiting	Not stated	2025-05-09		NCT04484701
PSMA PET/CT for Assessment of Recurrent Prostate Cancer	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Active, not recruiting	Not stated	2024-11-07		NCT02899312